DNA-PK inhibitors

COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

Carbazole EHop-016 derivatives as anticancer and anti-migratory agents

Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases

Bioactive molecule conjugate, preparation method and use thereof

Small molecule myristate inhibitors of Bcr-abl and methods of use

Substituted pyridazinone compound

Compounds and their use for reducing uric acid levels

MODULATORS OF THE INTEGRATED STRESS PATHWAY

Azole derivatives as apelin receptor agonist

Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

Compositions and methods for treating and preventing neurodegenerative disorders

Compounds with antimicrobial activity

HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions

Compounds and their use as inhibitors of N-myristoyl transferase

BICYCLIC DERIVATIVES

Substituted imidazoles for the treatment of cancer

PYRIMIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER

Compounds and their use for reducing uric acid levels

NOVEL COMPOUND AS INHIBITOR AGAINST BINDING OF PF34 PROTEIN TO NEDD4-1 PROTEIN AND USE THEREOF

BENZAMIDE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY DISEASE CONTAINING SAME AS ACTIVE INGREDIENT

Phenoxymethyl derivatives

Hydrazide containing nuclear transport modulators and uses thereof

Inhibitors of protein arginine deiminases (PADs) and methods of preparation and use thereof

Optical brightener for whitening paper

D-amino acid oxidase inhibitors and therapeutic uses thereof

DIMERIC CONTRAST AGENTS

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

Methionine metabolic pathway inhibitors

Cannabinoid receptor mediating compounds

C-Met Modulators and Methods of Use

Therapeutic compositions, combinations, and methods of use

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING MOTOR NEURON DISEASES

Heterocyclic amides useful as protein modulators

Quinazoline derivative or its salt and pharmaceutical composition comprising the same

Therapeutic compounds and uses thereof

Pyrimidine derivative kinase inhibitors

Pyrrole compounds

Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same

Compounds, Compositions and Methods

Crystalline FGFR4 inhibitor compound and uses thereof

PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND DERIVATIVES THEREOF

BICYCLIC QUINAZOLINONE DERIVATIVES

Carboxylic acid compounds

Compositions And Methods For Imaging Immune Cells

ErbB/BTK inhibitors

Methods for Treating MS Using Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

HETEROCYCLIC COMPOUNDS AS ANTIBACTERIALS

Biguanide derivatives and their rearrangement products for use in the treatment of cancer

Substituted pyrazole derivatives as selective CDK12/13 inhibitors

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

Substituted quinazolines for inhibiting kinase activity

Clozapine Immunoassay

Androgen receptor modulating compounds

Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective Mcl-1 inhibitors and as dual Mcl-1/Bcl-2 inhibitors

Sulfonylureas and related compounds and use of same

2,4-diamino-pyrimidine compounds and method for making and using the compounds

Synthesis of 2-indolinone derivatives

Organic electroluminescent compound and organic electroluminescent device comprising the same

Pyrrolidine derivative

WNT signaling pathway inhibitors for treatments of disease

PYRIMIDINEDIONE COMPOUNDS

ALLOSTERIC BCR-ABL PROTEOLYSIS TARGETING CHIMERIC COMPOUNDS

Type II raf kinase inhibitors

Chemical compounds

BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF

Pyrimidine derivatives

Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof

Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof

Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

Farnesoid X receptor agonists and uses thereof

Sulfonamide derivatives for protein degradation

N-substituted indole derivatives as PGE2 receptor modulators

SUBSTITUTED SULPHONAMIDES FOR CONTROLLING ANIMAL PESTS

Polymorphs of selinexor

N-(2,2-difluoroethyl)-N-[(pyrimidinylamino)propanyl]arylcarboxamides

Heteroaromatic compounds and their use as dopamine D1 ligands

KDM1A inhibitors for the treatment of disease

MEK inhibitors and methods of their use

Antibacterial compound and uses of same

Therapeutic compounds as inhibitors of the orexin-1 receptor

Pyrimidinyloxy benzene derivatives as herbicides

Compounds and their use for reducing uric acid levels

Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases

Photoresponsive low-molecular weight material, adhesive, toner, and image forming method

SUBSTITUTED ASYMMETRIC UREAS AS MODULATORS OF GHRELIN RECEPTOR ACTIVITY

Substituted isoquinolines as rock kinase inhibitors

1-cyano-pyrrolidine derivatives as inhibitors of USP30

Inhibitors of hepatitis C virus replication

Process for the preparation of Pazopanib or a pharmaceutically acceptable salt thereof

Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof

Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

6-membered heterocyclic derivatives and pharmaceutical composition comprising the same

Substituted heterocyclyl derivatives as CDK inhibitors

Lanthionine synthetase C-like 2-based therapeutics

HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS

TRPV4 antagonists

Potassium channel inhibitors

Quinazolines as potassium ion channel inhibitors

5-alkyl pyrrolidine orexin receptor agonists

Hydantoin containing deoxyuridine triphosphatase inhibitors

Carbazole derivatives

Phenylpyrrolidinone formyl peptide 2 receptor agonists

Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands

Quinazoline compounds as modulators of Ras signaling

Hetero-halo inhibitors of histone deacetylase

Pyrrole derivatives as PLK1 inhibitors

AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS, SALTS THEREOF, AND METHODS OF SYNTHESIS THEREOF

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY

Quinazolinones as PARP14 inhibitors

IL-17 ligands and uses thereof

CDK2 inhibitors

ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

Inhibitors of protein kinases

IDO/TDO inhibitor

Substituted pyrazole-pyrimidines, variants thereof, and uses therefore

Crystal forms of an androgen receptor antagonist, preparation method and use thereof

CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE

Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases

Antibacterial compounds

Pyrrole and pyrazole compounds and methods of use thereof

Pyrimidines and variants thereof, and uses therefor

EBNA1 inhibitors and methods using same

3-hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulators

3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides

PCSK9 inhibitors and methods of use thereof

Aryl substituted pyrimidines for use in influenza virus infection

N-[(pyrimidinylamino)propanyl]-,n-[pyridylamino)propanyl]- and n-[(pyrazinylaminol)propanyl]arylcarboxamides

Halogen complexes of compounds comprising at least one ether, thioether, and/or imine moiety and at least two lactam moieties

Fluorene derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition comprising same as effective ingredient for preventing or treating HCV-related disease

Bis-cyclic guanidines as antibacterial agents

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

Lysophosphatidic acid receptor 1 (LPAR1) inhibitor compounds

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same

Inhibitors of lysine specific demethylase-1

Compositions, methods, and systems for the synthesis and use of imaging agents

Nuclear transport modulators and uses thereof

Viral replication inhibitors

Bisamide sarcomere activating compounds and uses thereof

Bisamide sarcomere activating compounds and uses thereof

Phenoxyquinazoline compounds and their use in treating cancer

Glucose-6-Phosphate Dehydrogenase (G6PD)-Modulating Agents And Methods Of Treating G6PD Deficiency

P2X4 receptor antagonist

Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases

MARKERS, CONJUGATES, COMPOSITIONS AND METHODS FOR HYPOXIA IMAGING, MAPPING, AND THERAPY

PROCESS OF MAKING CENICRIVIROC AND RELATED ANALOGS

Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies

COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof

DIAZASPIROCYCLOALKANE AND AZASPIROCYCLOALKANE

Pyrimidine derivative, method for preparing same and use thereof in medicine

Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase

Benzimidazole derivatives as adenosine receptor antagonists

Combination of isoindolinone derivatives with SGI-110

Method for synthesis of protein amphiphiles

Class A GPCR-binding compound modifier

Cyanopyrrolidine derivatives with activity as inhibitors of USP30

Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists

Reactive oxygen species scavengers and use for treating diseases

Diarylhydantoin compounds and methods of use thereof

Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions

Compounds for treating proliferative diseases

Compounds and their use for reducing uric acid levels

Bacterial efflux pump inhibitors

Heteroarylphenylaminoquinolines and analogues

Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors

Nitrogenous heterocyclic compound, preparation method, intermediate, composition, and application

SUBSTITUTED SUCCINIMIDE DERIVATIVES AS PESTICIDES

Compound used as autophagy regulator, and preparation method therefor and uses thereof

THRβ receptor agonist compound and preparation method and use thereof

CONFORMATIONALLY STRAINED TRANS-CYCLOALKENES FOR RADIOLABELING

Compositions and methods for inhibition of the JAK pathway

Degradable imidazolium oligomer and polymer for antimicrobial applications

SUBSTITUTED 3-HETEROARYLOXY-1H-PYRAZOLES AND SALTS THEREOF AND THEIR USE AS HERBICIDAL ACTIVE SUBSTANCES

1-cyano-pyrrolidine compounds as USP30 inhibitors

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

Compounds and pharmaceutical compositions containing at least one of the compounds

Substituted cyanopyrrolidines with activity as DUB inhibitors

Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhibitors

Pyridazinone compound or its salt, and herbicide containing it

Compounds

Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereof

Inhibitors of lysine specific demethylase-1

Certain chemical entities, compositions, and methods

Pharmaceutical compound

Quinazoline and indole compounds to treat medical disorders

INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE AND HISTONE DEACETYLASE FOR TREATMENT OF CANCER

KRAS G12C inhibitors and methods of using the same

3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof

Polyfluoro-substituted aromatic heterocyclic derivative, pharmaceutical composition containing same, and applications thereof

INDOLE CARBOXAMIDE COMPOUNDS

Inhibitors of Rho associated coiled-coil containing protein kinase

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

COMPOUNDS, COMPOSITIONS AND METHODS

S1P3 antagonists

Fumarate analogs and uses thereof

Small molecule modulators of human sting

ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS

Substituted indole Mcl-1 inhibitors

LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS

Pyrimidine compound as JAK kinase inhibitor

Salt and polymorph of benzopyrimidinone compound and pharmaceutical composition and use thereof

Substituted isoquinolines and phthalazines as rock kinase inhibitors

Process for preparing 4-amino-pyridazines

Bacterial efflux pump inhibitors

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

Hepatitis B core protein modulators

Pyrazole derivatives for the treatment of cystic fibrosis

ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS

Pyridazines

Farnesoid X receptor agonists and uses thereof

NOVEL ANTI-INFLAMMATORY AGENTS

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN

Hepatitis B capsid assembly modulators

METHOD FOR THE SYNTHESIS OF AN N-ACYL COMPOUND WITHOUT THE USE OF ORGANIC SOLVENT OR ACID CHLORIDE

Substituted indoline derivatives as dengue viral replication inhibitors

Modulators of ATP-binding cassette transporters

Thyroid hormone receptor beta agonist compounds

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

FUSED-BICYCLIC ARYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF

2,3-dihydroisoindole-1-carboxamides useful as ROR-gamma modulators

Linkers for antibody drug conjugates

Methods for treating Huntington's disease

Benzathine analogs

Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide

DNA-PK inhibitors

Inhibitors of the fibroblast growth factor receptor

PKM2 modulators and methods for their use

Carbon monoxide releasing norbornenone compounds

INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USE THEREOF

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

Inhibitors of lysine specific demethylase-1

Inhibitors of integrated stress response pathway

Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof

Substituted phenazines and methods of treating cancer and bacterial diseases

4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS

Purified cenicriviroc and purified intermediates for making cenicriviroc

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

Quaternary amine compounds and antibody-drug conjugates thereof

Glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases

Selective ligand for dopamine D3 receptor, preparation method therefor, and pharmaceutical application thereof

Small molecule regulators of steroid receptor coactivators and methods of use thereof

2,4-pyrimidinediamine compounds and their uses

(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity

Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity

Positive allosteric modulators of the muscarinic acetylcholine receptor M

INHIBITORS OF BRUTONS TYROSINE KINASE

Hetroarylamine compounds for modulating the hedgehog pathway and preparing method and uses thereof

Pesticidal Compounds

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Benzene, Pyridine, and Pyridazine Derivatives

Biaryl piperidine amide compounds and methods of use thereof

Diphenylaminopyrimidine compound for inhibiting kinase activity

Method for producing benzimidazole derivative

Photoreactive ligands and uses thereof

N-SUBSTITUTED INDOLE DERIVATIVES

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

ANTI-CANCER STEMNESS DRUGS

HETEROCYCLIC AMIDES AS KINASE INHIBITORS

DNA-PK inhibitors

Inhibitors of human phosphatidylinositol 3-kinase delta

Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases

Pyrimidine derivatives for the treatment of viral infections

Piperidinyl-3-(aryloxy)propanamides and propanoates

O-aminoheteroaryl alkynyl-containing compound, preparation method therefor, and use thereof

Pyrimidinyloxy benzo-fused compounds as herbicides

SPIRO-COMPOUNDS AS SIP MODULATORS

Compositions and methods for modulating protease activity

Methods for preparing Nintedanib and intermediates thereof

Polymorph of pazopanib hydrochloride and preparation process thereof

WNT SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF

Substituted 2-(het)arylimidazolylcarboxyamides as pesticides

PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators

SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS

SUBSTITUTED BENZAMIDES

Theramutein modulators

Lanthionine synthetase C-like 2-based therapeutics

Organic electroluminescent element, display device, lighting device, π-conjugated compound, and light-emitting thin film

AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF

Compounds and methods for inhibiting fascin

Uracil containing compounds

Flame retardants

SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS

Benzimidazole compounds as c-Kit inhibitors

Compounds, devices, and uses thereof

CXCR4 CHEMOKINE RECEPTOR MODULATORS